Overview
Portfolio
More
Bioadvance
Conshohocken, United States
Portfolio
1+
Employees
5+
Founded
2003
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedSources
Bioadvance
Portfolio
1+
Employees
5+
Founded
2003
AUM
N/A
Showing 1 of 1 matched portfolio company
TalexMedical produces the InfantEar™ Molding System, a non-surgical Class I medical device designed to treat congenital ear deformities in newborns through a simple, pain-free molding process that lasts 2-3 weeks. This solution addresses the high prevalence of ear anomalies, which often do not self-correct, by providing a customizable, single-use kit that improves both the appearance and function of the ear.
Funding: $550.0K
Rough estimate of the amount of funding raised
BioAdvance
BioAdvance
Funding: $550.0K
Rough estimate of the amount of funding raised